“Comparison Of The Efficacy And Safety Of Secukinumab, Ustekinumab And Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis: A Systematic Review” (2023) Journal of Pharmaceutical Negative Results, pp. 485–495. doi:10.47750/pnr.2023.14.02.62.